- Home
- DYN vs PSNY Comparison
DYN vs PSNY Comparison
Compare DYN & PSNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DYN | PSNY |
|---|---|---|
| Founded | 1984 | 2017 |
| Country | United States | Sweden |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 1.8B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | DYN | PSNY |
|---|---|---|
| Price | $18.79 | $21.85 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 17 | 1 |
| Target Price | ★ $40.00 | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 413.5K |
| Earning Date | 02-26-2026 | 09-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,547,619,000.00 |
| Revenue This Year | N/A | $49.69 |
| Revenue Next Year | N/A | $44.50 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 24.82 |
| 52 Week Low | $6.36 | $11.75 |
| 52 Week High | $25.00 | $42.60 |
Technical Indicators
Market Signals| Indicator | DYN | PSNY |
|---|---|---|
| Relative Strength Index (RSI) | 45.69 | 75.16 |
| Support Level | $17.58 | $19.50 |
| Resistance Level | $21.00 | $23.28 |
| Average True Range (ATR) | 0.96 | 1.80 |
| MACD | -0.18 | 0.28 |
| Stochastic Oscillator | 34.16 | 88.16 |
Price Performance
Historical ComparisonAbout DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About PSNY Polestar Automotive Holding UK PLC ADS
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.